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A number of oxadiazole, thiadiazole and triazole
derivatives of 2-( 4-isobutylphenyl)propionic acid have
been synthesized and evaluated for their
antiinflammatory activity. The tested compounds show
77.2 to 48. 05% inhibition at 100 mg/kg dose compared
to ibuprofen which shows 61.04% inhibition at 100
mg/kg dose in carrageenin induced paw edema in rats.
Non-steroidal antiinflammatory drugs (NSAIDs)
are widely used in the treatment of rheumatoid
arthritis and inflammatory diseases. However, long
term NSAID use has been associated with
gastrointestinal (GI) ulceration, bleeding and
nephrotoxicity'. The tendency of many acidic
drugs to accumulate in the stomach wal1 soon after
oral absorption, has been considered as a
contributing factor to GI irritation". In addition
cyclooxygenase (CO) inhibition, which is the
principle mechanism for analgesic and
antiinflammatory properties of NSAID3 has also
been associated with nephrotoxicity and GI side
effects".
It has been reported that many nonacidic
antiinflammatory agents with comparable potency
to indomethacin have better GI tolerance in animal
models'. Meanwhile the replacement of the
carboxylic acid functionality of some NSAIDs e.g.
flufenamic and meclofenamic acids with a
tetrazole group not only retained CO inhibitory
activity of the parent drug, but also introduced 5-
Lipoxygenase (5-LO) inhibition" . Several other
heterocyclic compounds including di-tert butyl
phenyloxazoles, thiazoles or imidazoles' and
'Part of this work was presented at the 16th Asian Congress of
Pharmaceutical Sciences held in Nov. 1996 at Kualalumpur,
Malaysia.
Note
substituted oxadiazole, thiadiazole and tetrazole
derivatives'i" have been studied and proved to be
potent CO/5-LO inhibitors. Encouraged by these
observations we replaced the carboxylic acid group
of ibuprofen with a 1,3,4-oxadiazole/thiadiazole
and 1,2,4-triazole nucleus in the hope of obtaining
potential antiinflammatory agents.
The hydrazide 2 was prepared by esterification
of 2-(4-isobutylphenyl) propionic acid fol1owed by
treatment with hydrazine hydrate in absolute
ethanol. The hydrazide on treatment with aryliso-
thiocyanate in ethanol gave thiosemicarbazide
derivatives 3a-c in quantitative yield. The thio-
semicarbazides were oxidatively cyclised to 2-
arylamino-5-substituted 1,3,4-oxadiazoles 4a-c by
elimination of H2S using iodine and potassium
iodide in ethanolic sodium hydroxide. 2-AryI
amino-5-substituted 1,3,4-thiadiazoles Sa-c were
obtained by cyclisation of 3a-c by heating with
anhyd. orthophosphoric acid at 120°C for 45
minutes. The thiosemicarbazides on heating with
4N NaOH solution in ethanol for 1 hr underwent
smooth cyclisation through dehydration to afford
5-substituted-4-phenyl-3-mercapto-l,2,4-triazoles
6a-c. The hydrazide on reaction with carbon
disulphide in alkaline medium afforded, after
acidic treatment, 2-mercapto-5-substituted 1,3,4-
oxadiazole 7. The same hydrazide was transformed
into 2-amino-5-substituted-l,3,4-oxadiazole 8 by
reaction with cyanogen bromide and NaHC03 •
The structure of various compounds synthesized
were assigned on the basis of elemental analysis
and spectral data. The IR and 'H NMR spectral
data of compounds are given in experimental part.
The compounds were evaluated for their
antiinflammatory activity.
Antiinflammatory Activity: The compounds
4a,Sa,6a,7 and 8 were screened for their
antiinflammatory activity using rat paw edema
method of Winter et al.", Rat (either sex)
weighing 120 to 160 gms were divided into groups
of five animals each. A freshly prepared
suspension of carrageenin 0.1 mL 1% (w/v) was
injected subcutaneously into the plantar portion of
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the hind paw of each animal. One group was kept
control and the animals of the other group were
pretreated with the test drugs suspended in gum
acacia given orally 01 hr before the, carrageenin
treatment. The volume of the paw was measured
before and after 4 hrs of carrageenin treatment by
plethysmometer. Edema was calculated as the
difference between the two measurements.
Inhibition of swelling was determined by
comparing the change in hind paw volume in
compound and vehicle-treated rats.
Ibuprofen, the reference drug (100 mglkg, PO),
was found to inhibit 61.04% of edema produced by
injecting 0.1 mL of 1% (w/v) of carrageenin after 4
hrs. The results were quite significant in the
ibuprofen derivatives' in which the carboxylic
group has been replaced with various cyclic
moieties.
The results show that all the test compounds
4a,5a,6a,7 and 8 have antiinflammatory activity
showing 70.65, 77.92, 75.32, 48.05 and 66.23%
inhibition at 100 mglkg oral dose after 4 hrs. It was
observed that among the significantly active
compounds, the thiadiazole 5a and triazole 6a
were most potent and exhibited higher
antiinflammatory activity (77.92 and 75.32%
respectively) than ibuprofen, the standard
reference drug. On the other hand, among
oxadiazole derivatives compound 4a was most
potent (70.65%). The activity decreased in
aminooxadiazole 8 (66.23%) and minimum
activity was shown by mercaptooxadiazole 7
(48.05%)
Experimental Section
Melting points were determined in capillary
tubes and are uncorrected. IR spectra were
recorded on a Perkin-Elmer 157 infracord
spectrometer (vrnax in cmIjand IH NMR spectra on
a Bruker WM-400 (400 MHZ IT NMR)
spectrophotometer using TMS as internal reference
(chemical shift in 8 ppm). TLC was performed on
glass plates coated with silica gel-G pre activated at
110°C for 50 mins. Compounds were detected by
iodine vapours. 2-(4-Isobutyl)phenyl propionic
acid was procured from Ace Laboratories, New
Delhi, India.
Ethyl-2-(4-isobutyl phenyl)propionate 1. It
was prepared by the procedure given in the
literature 12.
2-(4-Isobutyl phenyl)-propionic acid
hydrazide 2. The compound was prepared as
reported in literature."
NI-[2-(4-Isobutyl phenyl) propionyl] N 4"aryl-
3-thiosemicarbazides 3a-c. The compounds were
prepared by the procedure given in the literature".
2-Phenylamino-5- [1-(4-isobutylphenyl)ethyl]-
1,3,4-oxadiazole 4a. To a stirred cooled solution
of the thiosemicarbazide derivative 3a (0.002
mole) in ethanol (50 mL) was added 1 mL of 5N
sodium hydroxide with cooling and shaking.
Iodine in potassium iodide solution (5%) was then
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added dropwise with stirring at room temperature
until the yellow colour of iodine persisted. The
mixture was refluxed on a water bath and more K1
solution was carefully added until a permanent
tinge of excess iodine was obtained. The reaction
mixture was gradually poured over crushed ice and
the solid mass which separated out was removed
by filtration, washed with water, dried and
recrystallised from ethanol. The compounds 4b,c
were prepared similarly and their m.ps and
elemental analysis are given in Table I. IR (KBr)
spectrum of the compounds 4a-c exhibited
absorption bands at 3100-3140 (NH), 2970-3000
(CH), 1640-1690 (C=N) and 1010-1025 (C-O-C).
'H NMR (DMSO-d6). spectrum of compound 4c
displayed signals at 1.0 {d, 6H 2CH3 ), 1.79 (m,
4H, CH and CH3 ), 2.34 (s, 3H, CH3), 2.6 (d, 2H,
CH2), 4.2 (q, IH, CH), 7.25 (m, 8H, Ar-H) and
7.74 (bs, IH, NH).
2-Phenylamino-5-[I-( 4-isobutylphenyl)ethyl)-
1,3,4-thiadiazole Sa. The thiosemicarbazide 3a
(0.03 mole) was added gradually, with stirring to
anhyd. orthophosphoric acid (10-15 mL) at 120°
during 20 min. The reaction mixture was heated
with stirring for another 2 hrs, cooled and poured
into crushed ice with stirring. The precipitated
mass was filtered, washed with water, dried and
recrystallised from methanol. The compounds 5b,c
were prepared similarly and their m.ps and
elemental analysis are given in Table I. The IR
(KBr) spectrum of the compounds 5a-c exhibited
bands at 3200-3260 (NH), 2900-2940 (CH) and
1640-1650 (C=N).
4-Phenyl-5-[I-(4-isobutyl phenyl) ethyl)-3-
mercapto-l,2,4-(H) triazole 6a. A suspension of
3a (0.0025 mole) in ethanol (20 mL) was dissolved
in aq. sodium hydroxide (4N, 2 mL) and gently
refluxed for 1 hr. The resulting solution was
treated with decolorising charcoal, cooled and
filtered. The filtrate was adjusted to pH 5-6 with
dilute acetic acid and the precipitated white solid
was filtered, washed with water, dried and
recrystallised from methanol. The compounds 6b,c
were prepared similarly and their m.ps and
elemental analysis are given in Table I. The IR
(KBr) spectrum of the compounds 6a-c exhibited
bands at 3100-3140 (NH), 2920-2940 (CH), 1200-
1210 (C=S). The 'H NMR (DMSO - d6) spectrum
of the compound 6a displayed signals at 0.88 (d,
6H,2CH3), 1.22 (d, 3H, CH3), 1.4 -1.6 (m burried,
IH, CH), 1.8 (d, 2H, CH2), 2.2 (q, IH, CH), 5.82
(s, IH, SH) and 7.2-7.8 (m, 9H, ArH).
5-[1-( 4-Isobutyl phenyl) etbyl)-2-mercapto-
1,3,4-oxadiazole 7. A mixture of acid hydrazide 2
(0.001 mole), potassium hydroxide (0.001 mole)
and carbon disulfide (1 mL) in ethanol (50 mL)
was refluxed for 6 hrs. The solution was
concentrated and allowed to cool overnight and
Table I-Physical constants of the synthesized compounds
Compd R' Molecular m.p. Req.(Found)%
formula °C C H N
4a H C2Ji2lNP 238 74.76 7.16 13.08
(74.32 7.37 12.86)
4b p-OCHJ C2IH25NJ02 234 71.79 7.12 11.96
(71.34 7.43 11.74)
4c p-CHJ C21H2SNP 244 75.22 7.46 12.53
(75.63 7.75 12.21)
Sa H C2Ji2lNJS 196 71.22 6.82 12.46
(71.47 6.54 12.15)
5b p-OCHJ C2IH25NPS 182 68.66 6.81 11.44
(68.23 6.54 11.16)
5c p-CHJ C2IH25NJS 180 71.79 7.12 11.96
(71.34 7.36 11.67)
6a H C2Ji2lNJS 188 71.22 6.82 12.46
(71.53 6.57 12.64)
6b p-OCHJ C21H2SNPS 220 68.66 6.81 11.44
(68.17 6.48 11.75)
6c p-CHJ C21H2SNJS 178 71.79 7.12 11.96
(71.37 7.29 11.64)
then poured into crushed ice. The resulting
solution was acidified with dilute HCI and allowed
to stand for 24 hrs. The separated solid was dried
and recrystallised from ethanol, yield 68%, m.p.
170°C (Found : C, 63.63; H 6.52; N, 10.94.
CI4HIsN20Srequires C, 64.12; H, 6.87; N, 10.68;.
IR (KBr) : 3250 (NH), 2950 (CH), 1140 (C=S);' IH
NMR (DMSO - d6) : 80.82 (d, 6H, 2CH3), 1.36 (d,
3H, CH3), 1.78 (m, IH, CH), 2.38 (d, 2H, CH2),
3.72 (q, IH, CH3CH), 7.01 - 7.18 (m, 10H, 9 ArH
and INH C=S).
2-Amino-5-( 1-(4-isobutyl phenyl) ethyIJ-l,3,4-
oxadiazole 8. To an ethanolic solution of 2 (0.002
mole), cyanogen bromide (0.01 mole) was added.
The reaction mixture was warmed at 55-60°C for
30 mins. The resulting clear solution was cooled
and neutralised with sodium bicarbonate solution
and allowed to stand for 4 hrs. The solid thus
separated was washed with water and
recrystallised from ethanol, yield 70%, m.p.
> 300°C (Found : C, 67.86; H, 8.45; N, 17.31.
CI4H2oN30requires C, 6K29; H, 8.13; N, 17.07%);
IR (KBr) : 3200 (NH), 2960 (CH), 1620 (C=N).
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